annual CFO:
-$207.79M-$54.17M(-35.26%)Summary
- As of today (July 27, 2025), COGT annual cash flow from operations is -$207.79 million, with the most recent change of -$54.17 million (-35.26%) on December 31, 2024.
- During the last 3 years, COGT annual CFO has fallen by -$149.03 million (-253.61%).
- COGT annual CFO is now -1272.90% below its all-time high of $17.72 million, reached on December 31, 2015.
Performance
COGT Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$66.51M-$5.93M(-9.80%)Summary
- As of today (July 27, 2025), COGT quarterly cash flow from operations is -$66.51 million, with the most recent change of -$5.93 million (-9.80%) on March 31, 2025.
- Over the past year, COGT quarterly CFO has dropped by -$13.98 million (-26.62%).
- COGT quarterly CFO is now -1054.50% below its all-time high of -$5.76 million, reached on June 30, 2017.
Performance
COGT quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$221.77M-$13.98M(-6.73%)Summary
- As of today (July 27, 2025), COGT TTM cash flow from operations is -$221.77 million, with the most recent change of -$13.98 million (-6.73%) on March 31, 2025.
- Over the past year, COGT TTM CFO has dropped by -$55.14 million (-33.09%).
- COGT TTM CFO is now -2951.36% below its all-time high of -$7.27 million, reached on March 31, 2017.
Performance
COGT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
COGT Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.3% | -26.6% | -33.1% |
| 3 y3 years | -253.6% | -134.7% | -192.8% |
| 5 y5 years | -400.5% | -742.7% | -536.0% |
COGT Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -253.6% | at low | -151.4% | at low | -147.3% | at low |
| 5 y | 5-year | -479.6% | at low | -699.0% | at low | -536.0% | at low |
| alltime | all time | -1272.9% | at low | -1054.5% | at low | -2951.4% | at low |
COGT Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$66.51M(+9.8%) | -$221.77M(+6.7%) |
| Dec 2024 | -$207.79M(+35.3%) | -$60.58M(+16.5%) | -$207.79M(+8.6%) |
| Sep 2024 | - | -$51.98M(+21.7%) | -$191.28M(+7.9%) |
| Jun 2024 | - | -$42.70M(-18.7%) | -$177.27M(+6.4%) |
| Mar 2024 | - | -$52.53M(+19.2%) | -$166.64M(+8.5%) |
| Dec 2023 | -$153.62M(+29.5%) | -$44.07M(+16.1%) | -$153.62M(+10.6%) |
| Sep 2023 | - | -$37.97M(+18.4%) | -$138.96M(+2.6%) |
| Jun 2023 | - | -$32.07M(-18.9%) | -$135.43M(+4.3%) |
| Mar 2023 | - | -$39.52M(+34.4%) | -$129.82M(+9.4%) |
| Dec 2022 | -$118.64M(+101.9%) | -$29.41M(-14.6%) | -$118.64M(+7.8%) |
| Sep 2022 | - | -$34.44M(+30.2%) | -$110.01M(+22.7%) |
| Jun 2022 | - | -$26.46M(-6.6%) | -$89.68M(+18.4%) |
| Mar 2022 | - | -$28.33M(+36.4%) | -$75.73M(+28.9%) |
| Dec 2021 | -$58.76M(+63.9%) | -$20.78M(+47.3%) | -$58.76M(+24.1%) |
| Sep 2021 | - | -$14.11M(+12.8%) | -$47.35M(+8.8%) |
| Jun 2021 | - | -$12.51M(+10.1%) | -$43.51M(+10.6%) |
| Mar 2021 | - | -$11.37M(+21.4%) | -$39.32M(+9.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$35.85M(-13.6%) | -$9.37M(-8.8%) | -$35.85M(+2.6%) |
| Sep 2020 | - | -$10.27M(+23.3%) | -$34.93M(+0.2%) |
| Jun 2020 | - | -$8.32M(+5.5%) | -$34.87M(-8.0%) |
| Mar 2020 | - | -$7.89M(-6.5%) | -$37.89M(-8.7%) |
| Dec 2019 | -$41.51M(+27.8%) | -$8.45M(-17.3%) | -$41.51M(-1.4%) |
| Sep 2019 | - | -$10.21M(-10.0%) | -$42.09M(+6.7%) |
| Jun 2019 | - | -$11.34M(-1.5%) | -$39.46M(+9.5%) |
| Mar 2019 | - | -$11.52M(+27.7%) | -$36.03M(+10.9%) |
| Dec 2018 | -$32.49M(+25.8%) | -$9.02M(+19.1%) | -$32.49M(+8.4%) |
| Sep 2018 | - | -$7.58M(-4.3%) | -$29.98M(+4.5%) |
| Jun 2018 | - | -$7.91M(-0.9%) | -$28.70M(+8.1%) |
| Mar 2018 | - | -$7.98M(+22.5%) | -$26.55M(+2.8%) |
| Dec 2017 | -$25.84M(+38.6%) | -$6.52M(+3.6%) | -$25.84M(+33.7%) |
| Sep 2017 | - | -$6.29M(+9.2%) | -$19.32M(+48.3%) |
| Jun 2017 | - | -$5.76M(-20.7%) | -$13.03M(+79.3%) |
| Mar 2017 | - | -$7.27M | -$7.27M |
| Dec 2016 | -$18.64M(-205.2%) | - | - |
| Dec 2015 | $17.72M | - | - |
FAQ
- What is Cogent Biosciences, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. annual CFO year-on-year change?
- What is Cogent Biosciences, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. quarterly CFO year-on-year change?
- What is Cogent Biosciences, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. TTM CFO year-on-year change?
What is Cogent Biosciences, Inc. annual cash flow from operations?
The current annual CFO of COGT is -$207.79M
What is the all time high annual CFO for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high annual cash flow from operations is $17.72M
What is Cogent Biosciences, Inc. annual CFO year-on-year change?
Over the past year, COGT annual cash flow from operations has changed by -$54.17M (-35.26%)
What is Cogent Biosciences, Inc. quarterly cash flow from operations?
The current quarterly CFO of COGT is -$66.51M
What is the all time high quarterly CFO for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high quarterly cash flow from operations is -$5.76M
What is Cogent Biosciences, Inc. quarterly CFO year-on-year change?
Over the past year, COGT quarterly cash flow from operations has changed by -$13.98M (-26.62%)
What is Cogent Biosciences, Inc. TTM cash flow from operations?
The current TTM CFO of COGT is -$221.77M
What is the all time high TTM CFO for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high TTM cash flow from operations is -$7.27M
What is Cogent Biosciences, Inc. TTM CFO year-on-year change?
Over the past year, COGT TTM cash flow from operations has changed by -$55.14M (-33.09%)